A
ISSUER//CIK 0001501756
Adverum Biotechnologies, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K252.3 KBAdverum Biotechnologies, Inc.Dec 9, 4:01 PM ET·0001193125-25-312722
- 8-K7.1 MBAdverum Biotechnologies, Inc.Dec 4, 4:36 PM ET·0001193125-25-308154
- 8-K231.4 KBAdverum Biotechnologies, Inc.Nov 21, 4:01 PM ET·0001193125-25-291327
- 10-Q5.5 MBAdverum Biotechnologies, Inc.Nov 12, 11:08 AM ET·0001628280-25-051593
- 8-K30.1 MBAdverum Biotechnologies, Inc.Nov 18, 4:05 PM ET·0001193125-24-260916
- SC 13G/A68.0 KBAdverum Biotechnologies, Inc.Nov 14, 6:57 PM ET·0001213900-24-098621
- SC 13G/A61.2 KBAdverum Biotechnologies, Inc.Nov 14, 6:40 PM ET·0000935836-24-000725
- SC 13G/A92.7 KBAdverum Biotechnologies, Inc.Nov 14, 4:05 PM ET·0001493152-24-045822
- SC 13G/A8.3 KBAdverum Biotechnologies, Inc.Nov 12, 9:50 AM ET·0000315066-24-002674
- SC 13G13.7 KBAdverum Biotechnologies, Inc.Nov 8, 2:17 PM ET·0002012383-24-003601
Insiders
10- Bain LindaChief Financial Officer
- Barone Samuel B.SVP, Clinical Development
- Beckman RichardChief Medical Officer
- Carter Eric GDirector
- Cheng Jennifer C.General Counsel
- Clark JulieChief Medical Officer
- Cleveland Paul BDirector, Chief Executive Officer
- Countouriotis AthenaSVP, Chief Medical Officer
- DeRespino ChristopherSee Remarks
- D'Souza RupertChief Financial Officer
Tickers
No tickers on record
Addresses
business
100 CARDINAL WAY
REDWOOD CITY, CA, 94063
mailing
100 CARDINAL WAY
REDWOOD CITY, CA, 94063
Former Names
- Adverum Biotechnologies, Inc.2025-12-19
- Avalanche Biotechnologies, Inc.2016-05-10